Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
Snoeck
R
R
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. robert.snoeck@rega.kuleuven.ac.be
Van Laethem
Y
Y
De Clercq
E
E
De Maubeuge
J
J
Clumeck
N
N
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000287:Administration, Topical; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001913:Bowen's Disease / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage* / Q000627:therapeutic use*; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D010412:Penile Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*; D014412:Tumor Virus Infections / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir